Lee S. Schwartzberg

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy”.

Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy

JCO Clinical Cancer Informatics(2024)10.1200/cci-24-00179

N/A

0.292DataRank · unranked

6 citations

Xin Hu, Sara Arshad, Janeane N. Anderson, Edward Stepanski, Gregory A. Vidal +3 more

Differences by race in patient-reported symptoms during chemotherapy among women with early-stage, hormone receptor-positive breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6528

N/A

0DataRank · unranked

0 citations

Cameron M. Kaplan, Edward Stepanski, Lee S. Schwartzberg, Gregory A. Vidal, Mark S. Walker +3 more

Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor–Positive Breast Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0692

N/A

0DataRank · unranked

12 citations

Cameron M. Kaplan, Michelle Y. Martin, Mark S. Walker, Edward Stepanski, Lee S. Schwartzberg +3 more

Race differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12102

N/A

0DataRank · unranked

0 citations

Mark S. Walker, Edward Stepanski, Cameron M. Kaplan, Michelle Y. Martin, Gregory A. Vidal +3 more

A randomized controlled trial of a mobile app and tailored messages to improve outcomes among women with breast cancer receiving adjuvant endocrine therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.512

N/A

0DataRank · unranked

3 citations

Xin Hu, Mehmet Koçak, Rebecca A. Krukowski, Janeane N. Anderson, Teresa M. Waters +6 more

Understanding health literacy's moderating role in remote monitoring for adjuvant endocrine therapy: Findings from a randomized clinical trial.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.45

N/A

0DataRank · unranked

0 citations

Xin Hu, Rebecca A. Krukowski, Mehmet Koçak, Janeane N. Anderson, Teresa M. Waters +5 more

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Annals of Surgical Oncology(2020)10.1245/s10434-019-08039-7

N/A

0DataRank · unranked

26 citations

Susanne Wagner, Darl D. Flake, Mark E. Robson, Lee S. Schwartzberg, Priyanka Sharma +7 more

Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf301

N/A

0DataRank · unranked

0 citations

Clara Cai, Sara Arshad, Janeane N. Anderson, Mylin A. Torres, Gregory A. Vidal +3 more